Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study. - Willasch AM; Peters C; Sedláček P; Dalle JH; Kitra-Roussou V; Yesilipek A; Wachowiak J; Lankester A; Prete A; Hamidieh AA; Ifversen M; Buechner J; et al. (Bone marrow transplantation, 2020)